 deep vein thrombosis:
Dispelling myths. Semin Vasc Surg 2005;18:148-52.
533. Weitz JI, Eikelboom JW, Samama MM. New antithrombotic drugs:
Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:
American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e120S-51S.
534. Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E,
Silingardi M. WARFASA Investigators. Aspirin for preventing the
recurrence of venous thromboembolism. N Engl J Med 2012;366:
1959-67.
535. Hull RD, Pineo GF, Brant R, Liang J, Cook R, Solymoss S, et al.
Home therapy of venous thrombosis with long-term LMWH versus
usual care: Patient satisfaction and post-thrombotic syndrome. Am J
Med 2009;122:762-9.e3.
536. Hull RD, Liang J, Townshend G. Long-term low-molecular-weight
heparin and the post-thrombotic syndrome: A systematic review.
Am J Med 2011;124:756-65.
537. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, et al. Ddimer testing to determine the duration of anticoagulation therapy.
N Engl J Med 2006;355:1780-9.
538. Siragusa S, Malato A, Saccullo G, Iorio A, Di Ianni M, Caracciolo C,
et al. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower
limbs: The extended DACUS study. Am J Hematol 2011;86:914-7.
539. Carrier M, Rodger MA, Wells PS, R